Please login to the form below

Innovative Trials named Best global Patient Recruitment Company of 2021

Innovative Trials, has been named Best Global Patient Recruitment Company by the Healthcare & Pharmaceutical Awards 2021.

Innovative Trials, has been named Best Global Patient Recruitment Company by the Healthcare & Pharmaceutical Awards 2021. The awards, organised by Global Health & Pharma and now in their sixth year, aim to recognise ‘innovation, determination and outstanding levels of care demonstrated by those who place our wellbeing at the forefront of their practice’.

Founded in 2010, Innovative Trials is a UK-based company that works with some of the biggest pharmaceutical companies and Clinical Research Organisations (CROs) globally to help them reach their patient recruitment targets for trials, keep patients engaged and avoid costly delays in bringing effective new treatments to market. With a mission to accelerate recruitment to help bring treatments to patients sooner, the company has so far:

● worked on nearly 200 clinical trials
● recruited around 40,000 people into clinical trials
● played a part in six new treatments being approved for patients across the world.

In 2020, Innovative Trials also launched a campaign alongside two other organisations to ensure patients from under-represented ethnic groups are fairly represented in UK clinical and health research.

Kate Shaw, founder and CEO of Innovative Trials, said: “We are thrilled to receive such a ringing endorsement of our work, which is entirely due to the dedication of every single member of the team. At the heart of what we do is the drive to get life-changing medicines to patients more quickly; any delays to the clinical trial process inevitably means delays in getting potentially effective treatments to those who need them most. Indeed, one of our areas of expertise lies in supporting trials in danger of failing due to lack of participants. We work closely with sites and local communities to develop tailored strategies to engage, recruit and retain patients to ensure the trial can continue. It is one of the reasons our clients come back to us again and again.”

The Healthcare & Pharmaceutical Award is the second accolade to be given to Innovative Trials this year. The company was presented with a Queen’s Award for Enterprise in International Trade in June for its work to help bring new medicines to market.

For more information about Innovative Trials, visit

29th September 2021



Company Details

Innovative Trials

+44 (0) 1707 378 581

Contact Website

Innovative Trials Ltd, Innovative House
Avenue One
Letchworth Garden City
United Kingdom

Latest content on this profile

Kate Shaw reflects on Innovative Trials' first US office openings
On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening
Innovative Trials
Innovative Trials on the latest ABPI report
Kate Shaw, Innovative Trials Founder & CEO, commented on the latest ABPI report
Innovative Trials
Innovative Trials featuring in a Clinical Trials Arena article
Leanne Keem, Head of Operations and Client Relationship at Innovative Trials, featured in a recent article.
Innovative Trials
Overcoming Patient Recruitment Challenges in Rare Disease Trials
Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new and effective treatments.We know patient recruitment can be challenging even for non-complex trials, but this issue is exacerbated for rare disease studies due to the much smaller patient populations involved. This can lead to lengthy delays in bringing what can be cutting-edge and potentially life-changing therapies to market.With the global rare disease market expected to be worth more than US$547 billion within the next 10 years overcoming these challenges is critical. This webinar will:explore some of the patient recruitment challenges in rare disease studies, particularly relating to sickle cell trialshear from a patient and family member about what it means to live with a rare disease and highlight strategies to accelerate patient recruitment for these specialized trials.Learning ObjectivePatient recruitment challenges in rare disease studiesChallenges in sickle cells studiesFamily/Patient perspectiveAccelerating patient recruitment in rare disease studiesSpeaker 1 - Whitney Taynton - Business Unit Head, Site Enrollment Optimization, Innovative TrialsSpeaker 2 - Donna Dail - Director, Patient Recruitment Programs (Rare Disease)Speaker 3 - Margaret Alege - Patient
Innovative Trials
FREE Live Webinar - Overcoming Patient Recruitment Challenges in Rare Disease Trials
Innovative Trials and Pfizer invite you to attend the live webinar
Innovative Trials
Innovative Trials opens first US office
We are incredibly excited to announce the opening of our very first US office! This is an incredible milestone towards our mission to accelerate clinical development. Read the full press release here: Innovative Trials website: Follow our social media. LinkedIn: Instagram: Twitter: Facebook:
Innovative Trials